Biological materials to aid in soft and osseous tissue regeneration (endodontic/dental)
Defines documentation and clinical criteria under which biologic materials used to aid soft tissue and osseous tissue regeneration in dental procedures may be reviewed and considered for coverage when allowed by specific group contracts. Provides coding examples (CDT) for informational purposes and lists exclusions/limitations for use.
Document updated and last reviewed 10/21/2022 with effective date 01/01/2023.
Coverage Summary
Overview: This policy (Policy Number 03-401) addresses the use of biologic materials to aid in soft tissue and osseous tissue regeneration as adjunctive regenerative therapy for periodontal defects of natural teeth and for implants. Reviews are performed to ensure services meet contractual requirements and generally accepted standards of dental care. Effective date: 2023-01-01; Last review date: 2022-10-21.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.